The COMPASSION Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute
About this trial
The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.
Eligibility criteria
Qualifiers
Patient of any gender with unresectable locally advanced or metastatic breast cancer
Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice </= 1 week before enrollment
Ability to conduct video or phone check-ins, even if assistance required.
Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
Disqualifiers
Unable to provide verbal consent
Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
Hospice setting outside of Massachusetts
Individuals who are under the age of 18, as this is not a project focused on pediatric patients.
Trial design
Treatments tested in this trial
- Telehealth Hospice Visits
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov